Overview

Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)

Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess safety and efficacy of intravitreal injection of Conbercept on visual acuity and anatomic outcomes in patients with diabetic macular edema (DME) .
Phase:
Phase 3
Details
Lead Sponsor:
Chengdu Kanghong Biotech Co., Ltd.
Chengdu Kanghong Biotech Co.,Ltd.